Risperidone plasma concentrations are associated with side effects and effectiveness in children and adolescents with autism spectrum disorder

A Comparison of Pediatric and Adult Safety Studies for Antipsychotic and Antidepressant Drugs Submitted to the United States Food and Drug Administration

(2019) Xiaomei I. Liu et al.   JOURNAL OF PEDIATRICS

Clinical Pharmacokinetics of Atypical Antipsychotics: An Update

(2018) Massimo Carlo Mauri et al.   CLINICAL PHARMACOKINETICS

Antipsychotics in Dutch Youth: Prevalence, Dosages, and Duration of Use from 2005 to 2015

(2018) Sanne M. Kloosterboer et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Clinical applications of population pharmacokinetic models of antibiotics: Challenges and perspectives

(2018) Femke de Velde et al.   PHARMACOLOGICAL RESEARCH

Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017

(2018) C. Hiemke et al.   PHARMACOPSYCHIATRY

Dried Blood Spot Analysis for Therapeutic Drug Monitoring of Antipsychotics

(2018) Sanne M. Kloosterboer et al.   THERAPEUTIC DRUG MONITORING

A Focused Review on the Treatment of Pediatric Patients with Atypical Antipsychotics

(2018) Esther S. Lee et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Concentration-Effect Relationships of Psychoactive Drugs and the Problem to Calculate Therapeutic Reference Ranges

(2018) Christoph Hiemke   THERAPEUTIC DRUG MONITORING

International trends in antipsychotic use: A study in 16 countries, 2005–2014

(2017) Óskar Hálfdánarson et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Serum Concentration of Risperidone and Adverse Effects in Children and Adolescents

(2017) Amilton dos Santos-Júnior et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Impact of CYP2D6 Polymorphism on Steady-State Plasma Levels of Risperidone and 9-Hydroxyrisperidone in Thai Children and Adolescents with Autism Spectrum Disorder

(2017) Natchaya Vanwong et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Dried Blood Spots Combined With Ultra–High-Performance Liquid Chromatography–Mass Spectrometry for the Quantification of the Antipsychotics Risperidone, Aripiprazole, Pipamperone, and Their Major Metabolites

(2017) Camille Tron et al.   THERAPEUTIC DRUG MONITORING

9-Hydroxyrisperidone-Induced Hyperprolactinaemia in Thai Children and Adolescents with Autism Spectrum Disorder

(2016) Nattawat Ngamsamut et al.   BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY

Influence of CYP3A5 polymorphism on the pharmacokinetics of psychiatric drugs

(2016) Georgia Ragia et al.   CURRENT DRUG METABOLISM

Antipsychotic Use Trends in Youth With Autism Spectrum Disorder and/or Intellectual Disability: A Meta-Analysis

(2016) Su Young Park et al.   JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY

Pharmacologic Treatment of Severe Irritability and Problem Behaviors in Autism: A Systematic Review and Meta-analysis

(2016) L. K. Fung et al.   PEDIATRICS

Identification and quantification of the antipsychotics risperidone, aripiprazole, pipamperone and their major metabolites in plasma using ultra-high performance liquid chromatography-mass spectrometry

(2015) Rixt A. Wijma et al.   BIOMEDICAL CHROMATOGRAPHY

Genetics-Based Population Pharmacokinetics and Pharmacodynamics of Risperidone in a Psychiatric Cohort

(2015) Frederik Vandenberghe et al.   CLINICAL PHARMACOKINETICS

Therapeutic drug monitoring of second-generation antipsychotics in pediatric patients: an observational study in real-life settings

(2015) Marco Pozzi et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Corrected QT Changes During Antipsychotic Treatment of Children and Adolescents: A Systematic Review and Meta-Analysis of Clinical Trials

(2015) Karsten Gjessing Jensen et al.   JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY

Antipsychotics and the Risk of Type 2 Diabetes Mellitus in Children and Youth

(2013) William V. Bobo et al.   JAMA Psychiatry

Risk of Hyperprolactinemia and Sexual Side Effects in Males 10–20 Years Old Diagnosed with Autism Spectrum Disorders or Disruptive Behavior Disorder and Treated with Risperidone

(2012) Yvette Roke et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Adverse Effects of Second-Generation Antipsychotics in Children and Adolescents

(2012) David Cohen et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Population Pharmacokinetic Modeling of Risperidone and 9-Hydroxyrisperidone to Estimate CYP2D6 Subpopulations in Children and Adolescents

(2012) Catherine M. T. Sherwin et al.   THERAPEUTIC DRUG MONITORING

Obesity and Allometric Scaling of Pharmacokinetics

(2011) Douglas J. Eleveld et al.   CLINICAL PHARMACOKINETICS

Metabolic and endocrine adverse effects of second-generation antipsychotics in children and adolescents: A systematic review of randomized, placebo controlled trials and guidelines for clinical practice

(2011) M. De Hert et al.   EUROPEAN PSYCHIATRY

Predictors of Risperidone and 9-Hydroxyrisperidone Serum Concentration in Children and Adolescents

(2011) Chadi Albert Calarge et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Facilitating pharmacokinetic studies in children: a new use of dried blood spots

(2010) P. Patel et al.   ARCHIVES OF DISEASE IN CHILDHOOD

Population Pharmacokinetics of Oral Risperidone in Children, Adolescents and Adults with Psychiatric Disorders

(2010) An Thyssen et al.   CLINICAL PHARMACOKINETICS

Risperidone-Induced Weight Gain in Referred Children with Autism Spectrum Disorders Is Associated with a Common Polymorphism in the 5-Hydroxytryptamine 2C Receptor Gene

(2010) Pieter J. Hoekstra et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Serum Concentrations, Therapeutic Response and Side Effects in Children and Adolescents with Impulsive-Aggressive Symptoms during Risperidone Therapy

(2010) K. Klampfl et al.   PHARMACOPSYCHIATRY

Weight Gain and Metabolic Abnormalities During Extended Risperidone Treatment in Children and Adolescents

(2009) Chadi A. Calarge et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Antipsychotic Medication in Children and Adolescents: A Descriptive Review of the Effects on Prolactin Level and Associated Side Effects

(2009) Yvette Roke et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Pharmacogenetics of risperidone therapy in autism: association analysis of eight candidate genes with drug efficacy and adverse drug reactions

(2009) C T Correia et al.   PHARMACOGENOMICS JOURNAL

Short- and long-term effects on prolactin of risperidone and olanzapine treatments in children and adolescents

(2009) Gaetana Migliardi et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Computing normalised prediction distribution errors to evaluate nonlinear mixed-effect models: The npde add-on package for R

(2008) Emmanuelle Comets et al.   COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE

Accurate electrocardiographic assessment of the QT interval: Teach the tangent

(2008) Pieter G. Postema et al.   HEART RHYTHM

Lipid Screening and Cardiovascular Health in Childhood

(2008) S. R. Daniels et al.   PEDIATRICS

ABCB1 Polymorphisms Influence Steady-State Plasma Levels of 9-Hydroxyrisperidone and Risperidone Active Moiety

(2008) Arzu Gunes et al.   THERAPEUTIC DRUG MONITORING

Relationship between prolactin secretion, and plasma risperidone and 9-hydroxyrisperidone concentrations in adolescents with schizophreniform disorder

(2007) Fabrice Duval et al.   PSYCHONEUROENDOCRINOLOGY